Combined effect of xanthinol nicotinate and low molecular weight dextran on survival of dogs subjected to acute hemorrhagic shock.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003911:Dextrans / Q000627:therapeutic use*; D004285:Dogs; D004338:Drug Combinations; D005260:Female; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use*; D012771:Shock, Hemorrhagic / Q000188:drug therapy* / Q000401:mortality; D013806:Theophylline / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D003911:Dextrans; D004338:Drug Combinations; D009539:Nicotinic Acids; D013806:Theophylline